InvestorsHub Logo
Followers 18
Posts 643
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Thursday, 06/11/2020 10:46:12 AM

Thursday, June 11, 2020 10:46:12 AM

Post# of 403092
But hey...no big deal, right?!

“The proposed research aims to evaluate Brilacidin as a potential pan-coronavirus therapeutic, for treating SARS-CoV-2, SARS-CoV-1 and MERS-CoV, including extending the current in vitro testing of Brilacidin to in vivo testing. Longer-term objectives include potentially performing additional research to develop Brilacidin as a broad-spectrum antiviral, with possible application beyond coronaviruses, e.g., treating other viruses, such as encephalitic alphaviruses and filoviruses.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News